文献速递骨质疏松与代谢性骨病关节外科

痛风是骨质疏松症的危险因素:一项基于人群的108,060人纵向流行病学研究

Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
PubMed 文献 · Osteoporos Int · 2018-01-30

这项基于全国人群的回顾性配对队列研究纳入36,458例痛风患者和71,602例无痛风者,随访8年。痛风组骨质疏松累积发生率3.3%高于非痛风组的2.1%(P=0.0036),校正后风险比aHR为1.2(95%CI 1.06-1.35)。

要点

  • 痛风患者未来发生骨质疏松的风险较无痛风者轻度升高,校正后aHR为1.2(95%CI 1.06-1.35)。
  • 痛风组骨质疏松累积发生率为3.3%,非痛风组为2.1%(P=0.0036,log-rank检验)。
  • 该研究为基于人群的流行病学研究,支持痛风与未来骨质疏松风险轻度增加相关的假设。

核心结论

  • 这项首个基于人群的流行病学研究支持以下假设:与无痛风者相比,痛风患者未来发生骨质疏松的风险轻度增加。

研究设计与样本

  • 排除标准为数据缺失、年龄小于20岁、随访时间短及既往已患骨质疏松;两队列随访至发生骨质疏松、死亡或研究结束。
  • 研究计算人年数据与发病率,并采用多变量Cox模型在校正社会经济替代指标、地理差异、糖皮质激素与别嘌醇暴露、多种预设医疗状况及合并症后得出校正风险比(aHR)。

主要发现

  • 队列中男性占72.8%;痛风组随访183,729人年、非痛风组随访359,900人年,在排除随访前3年内发生的骨质疏松事件后,分别发生517例和811例骨质疏松。
  • 痛风组骨质疏松累积发生率为3.3%,非痛风组为2.1%,痛风组统计学上高于非痛风组(P=0.0036,log-rank检验)。
  • Cox模型显示痛风队列骨质疏松发病率增加1.2倍,aHR为1.2(95%置信区间1.06-1.35)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Is gout a risk factor for future osteoporosis? This large population-based study comprising two matched groups of individuals with and without gout demonstrates that patients with gout have a 20% increase in the risk of developing osteoporosis in future through an 8-year follow-up. INTRODUCTION: To examine if gout is associated with an increased risk of osteoporosis. METHODS: We conducted a nationwide population-based retrospective matched-cohort study. Two matched cohorts (n = 36,458 with gout and 71,602 without gout) assembled and recruited from the Longitudinal Health Insurance Dataset containing 1 million subjects. Exclusion criteria were missing data, age < 20 years, short follow-up period, and pre-existing osteoporosis. Both cohorts were followed up until incident osteoporosis, death, or the end of the study. Person-year data and incidence rates were evaluated. A multivariable Cox model was used to derive an adjusted hazard ratio (aHR) after controlling for socioeconomic proxy, geographical difference, glucocorticoid and allopurinol exposure, various prespecified medical conditions, and comorbidities. RESULTS: Men comprised 72.8% of the cohorts. With a follow-up of 183,729 and 359,900 person-years for the gout and non-gout cohorts, 517 and 811 incidents of osteoporosis occurred, respectively, after excluding osteoporosis incidents in the first 3 years of follow-up. The cumulative incidence of osteoporosis was statistically higher in the gout cohort than in the non-gout cohort, at 3.3 versus 2.1% (P = 0.0036, log-rank). Our Cox model showed a 1.2-fold increase in the incidence of osteoporosis in the gout cohort, with an aHR of 1.2 (95% confidence interval, 1.06-1.35). CONCLUSIONS: This first population-based epidemiologic study supports the hypothesis that compared with individuals without gout; those with gout have a modest increase in the risk of developing osteoporosis in future.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Kok VC, Horng JT, Wang MN, et al. Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos Int. 2018. PMID: 29383389. doi:10.1007/s00198-018-4375-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。